NEW YORK (GenomeWeb News) – University of North Carolina at Chapel Hill researchers have won a $2.4 million grant to study genetic variations in diabetes patients in order to predict response to treatment and reduce cardiovascular disease, UNC said Monday.

Funded by the National Heart, Lung, and Blood Institute, the four-year study will be led by the North Carolina Translational and Clinical Sciences Institute, which is the academic home of the National Institutes of Health's Clinical and Translational Science Award at UNC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.